Loupakis, Fotios
Biason, Paola
Prete, Alessandra Anna
Cremolini, Chiara
Pietrantonio, Filippo
Pella, Nicoletta
Dell’Aquila, Emanuela
Sperti, Elisa
Zichi, Clizia
Intini, Rossana
Dadduzio, Vincenzo
Schirripa, Marta
Bergamo, Francesca
Antoniotti, Carlotta
Morano, Federica
Cortiula, Francesco
De Maglio, Giovanna
Rimassa, Lorenza
Smiroldo, Valeria
Calvetti, Lorenzo
Aprile, Giuseppe
Salvatore, Lisa
Santini, Daniele
Munari, Giada
Salmaso, Roberta
Guzzardo, Vincenza
Mescoli, Claudia
Lonardi, Sara
Rugge, Massimo
Zagonel, Vittorina
Di Maio, Massimo
Fassan, Matteo
Article History
Received: 30 May 2019
Accepted: 9 August 2019
First Online: 2 September 2019
Competing interests
: F.L. had roles as consultant or advisor for Roche, Bayer, Amgen, Genentech. F.P. received honoraria and had roles as consultant or advisor for Amgen, Merck, Roche, Sanofi, Bayer, Servier, Lilly. S.L. had roles as consultant or advisor for Amgen, Bayer, Merck Serono, Lilly. She received research funding from Amgen, Merck Serono and she is part of speakers’ bureau of Lilly, BMS. Vittorina Zagonel received honoraria and had roles as consultant or advisor for Bristol-Mayers Squibb, Bayer, Roche, Pfizer, Janssen, Novartis, Astellas, Servier. She had roles as consultant or advisor for Celgene, Merck. M.D.M. received honoraria and had roles as consultant or advisor for AstraZeneca, Bristol Myers Squibb, MSD, Takeda and Janssen; received a research grant from Tesaro. M.F. received a research grant from Astellas Pharma. The remaining authors declare no competing interest.
: The study was approved by the Ethics Committee of Veneto Institute of Oncology (ID CESC IOV 186/2017) and was conducted according to ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Patients provided additional Informed Consent when appropriate
: Regione Veneto – RP-2014-00000395., DOR Funds University of Padua.
: No individual person’s data were reported in any form in the paper.
: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).